Hallucinogen dependence with hallucinogen-induced anxiety disorder
ICD-10 F16.280 is a billable code used to indicate a diagnosis of hallucinogen dependence with hallucinogen-induced anxiety disorder.
Hallucinogen dependence with hallucinogen-induced anxiety disorder refers to a condition where an individual exhibits a compulsive pattern of hallucinogen use, leading to significant impairment or distress. This dependence is characterized by a strong desire to consume hallucinogens, tolerance to their effects, and withdrawal symptoms when not using. The anxiety disorder component indicates that the individual experiences anxiety symptoms directly attributable to hallucinogen use, which may include panic attacks, excessive worry, or fear that is disproportionate to the situation. These symptoms can persist even after the acute effects of the drug have worn off, complicating the clinical picture. Treatment often involves a combination of psychotherapy, such as cognitive-behavioral therapy, and pharmacotherapy to manage anxiety symptoms. The interplay between substance dependence and anxiety disorders necessitates a comprehensive treatment approach to address both issues effectively.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with anxiety symptoms following hallucinogen use, or those with a history of substance use seeking treatment.
Consideration of the impact of hallucinogen use on existing mental health conditions.
Comprehensive assessment of substance use, including frequency, quantity, and impact on daily functioning.
Patients in withdrawal or seeking detoxification services for hallucinogen dependence.
Integration of behavioral therapies with pharmacological treatments for anxiety.
Used for follow-up visits for patients with hallucinogen dependence and anxiety.
Document the patient's history, current symptoms, and treatment plan.
Psychiatrists may need to provide additional details on the patient's mental health status.
Hallucinogen dependence refers to the compulsive use of hallucinogens leading to tolerance and withdrawal, while hallucinogen-induced anxiety disorder is characterized by anxiety symptoms that arise directly from hallucinogen use. Both conditions can occur simultaneously, necessitating careful documentation and treatment.
